Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Administration of Insulin to Type 1 Diabetes-current Nursing Practice


Affiliations
1 Annamalai University, Annamalai Nagar, Chennai, India
2 Rani Meyyammai College of Nursing, Annamalai University, Annamalai Nagar, Chennai, India
3 Director of Juvenile Diabetes Projects,voluntary Health Services, Chennai, India
     

   Subscribe/Renew Journal


The International Diabetes Federation's (IDF) diabetes atlas 2011 shows that 366 million people have diabetes worldwide and by 2030, this will have risen to 552 million. At the same time, 183 million people (50%) with diabetes are undiagnosed1. Current estimates suggest that two thirds of those affected by diabetes live in low and middle income countries (LMIC). By 2025, the number of diabetes cases will increase by 170% in low and middle income countries, compared to a 41% increase in developed countries2. The total child population (0-14 years) was 1.9 billion worldwide. Some 78,000 children under 15 years are estimated to develop type 1 diabetes annually worldwide. About 49,000 children were affected with type 1 diabetes with 24% from European region and 23% from South East Asian region1. Insulin is an important hormone concerned with regulation of carbohydrate, protein and fat metabolism and blood glucose level. Insulin has been identified as one of the top 10 high risk medicines in treating type 1 diabetes3.

Keywords

Insulin, Type 1 Diabetes, Insulin Therapy, Insulin Administration, Insulin Delivery
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 608

PDF Views: 4




  • Administration of Insulin to Type 1 Diabetes-current Nursing Practice

Abstract Views: 608  |  PDF Views: 4

Authors

Anjuladevi Kamaraj
Annamalai University, Annamalai Nagar, Chennai, India
M. Gandhimathi
Rani Meyyammai College of Nursing, Annamalai University, Annamalai Nagar, Chennai, India
C. Ramesh
Director of Juvenile Diabetes Projects,voluntary Health Services, Chennai, India

Abstract


The International Diabetes Federation's (IDF) diabetes atlas 2011 shows that 366 million people have diabetes worldwide and by 2030, this will have risen to 552 million. At the same time, 183 million people (50%) with diabetes are undiagnosed1. Current estimates suggest that two thirds of those affected by diabetes live in low and middle income countries (LMIC). By 2025, the number of diabetes cases will increase by 170% in low and middle income countries, compared to a 41% increase in developed countries2. The total child population (0-14 years) was 1.9 billion worldwide. Some 78,000 children under 15 years are estimated to develop type 1 diabetes annually worldwide. About 49,000 children were affected with type 1 diabetes with 24% from European region and 23% from South East Asian region1. Insulin is an important hormone concerned with regulation of carbohydrate, protein and fat metabolism and blood glucose level. Insulin has been identified as one of the top 10 high risk medicines in treating type 1 diabetes3.

Keywords


Insulin, Type 1 Diabetes, Insulin Therapy, Insulin Administration, Insulin Delivery